BVS

BVS EBITDA Growth

22.91%TTM

Period ending:

BVS TTM EBITDA YoY %%
BVS TTM EBITDA YoY %458.04%-1597.11%
2020-06-302026-06-27

Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.

BVS ebitda growth history

Year-over-year EBITDA growth rate. The available trailing twelve months (ttm) series contains 24 observations from Jun 30, 2020 to Jun 27, 2026.

Bioventus Class A Inc EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
22.9087%
186.7449%
170.1909%
204.8637%
199.39%
-46.6919%
259.1547%
159.9348%
115.8236%
135.461%
81.4989%
53.2396%
-1,280.3802%
-1,398.2288%
-339.8627%
-285.4642%
-77.5946%
-76.3173%
-2.013%
-3.0105%
8.5722%
-8.4366%
14.491%
127.4296%

Compare ebitda growth

All BVS financial metrics · BVS stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.